Lily Liu

1.1k total citations · 1 hit paper
8 papers, 917 citations indexed

About

Lily Liu is a scholar working on Radiology, Nuclear Medicine and Imaging, Immunology and Cancer Research. According to data from OpenAlex, Lily Liu has authored 8 papers receiving a total of 917 indexed citations (citations by other indexed papers that have themselves been cited), including 3 papers in Radiology, Nuclear Medicine and Imaging, 3 papers in Immunology and 3 papers in Cancer Research. Recurrent topics in Lily Liu's work include Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Immune Response and Inflammation (2 papers). Lily Liu is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (3 papers), CAR-T cell therapy research (2 papers) and Immune Response and Inflammation (2 papers). Lily Liu collaborates with scholars based in United States, Germany and China. Lily Liu's co-authors include Dean W. Ballard, Timothy A. McKinsey, Zhi‐Liang Chu, Michael H. Malim, Xiaoxia Qi, Ja‐Liang Lin, Lihua Wang, Jeng‐Yi Huang, Dan‐Tzu Lin‐Tan and Yenlin Huang and has published in prestigious journals such as Proceedings of the National Academy of Sciences, Molecular and Cellular Biology and Cancer Research.

In The Last Decade

Lily Liu

7 papers receiving 905 citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control

1997 778 citations Zhi‐Liang Chu, Timothy A. McKinsey et al. Proceedings of the National Academy of Sciences profile →

Peers

Countries citing papers authored by Lily Liu

Since Specialization

Citations

This map shows the geographic impact of Lily Liu's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Lily Liu with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Lily Liu more than expected).

Fields of papers citing papers by Lily Liu

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Lily Liu. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Lily Liu. The network helps show where Lily Liu may publish in the future.

Co-authorship network of co-authors of Lily Liu

This figure shows the co-authorship network connecting the top 25 collaborators of Lily Liu. A scholar is included among the top collaborators of Lily Liu based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Lily Liu. Lily Liu is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

8 of 8 papers shown

#	Work	Indexed citations
1	WSD-0922, a novel brain-penetrant inhibitor of epidermal growth factor receptor, promotes survival in glioblastoma mouse models 2023 ·Neuro-Oncology Advances ·(unknown), Sylwia A. Stopka, Ju‐Hee Oh, Ann C. Mladek, Danielle M. Burgenske, Michael S. Regan, Gerard Baquer, Paul A. Decker, Brett L. Carlson, Katrina K. Bakken, Jinqiang Zhang, Lily Liu, (unknown), (unknown), Wei Zhong, Nhan L. Tran, William F. Elmquist, Nathalie Y.R. Agar, Jann N. Sarkaria, Forest M. White	4
2	A Junction Temperature Monitoring Method Based on Turn-Off Current for IGBT Modules 2023 ·Lily Liu, Xinglai Ge, Huimin Wang, (unknown), (unknown)	0
3	Characterization of an Anti-CD70 Half-Life Extended Bispecific T-Cell Engager (HLE-BiTE) and Associated On-Target Toxicity in Cynomolgus Monkeys 2022 ·Toxicological Sciences ·(unknown), Amy Sharma, (unknown), (unknown), (unknown), Lily Liu, (unknown), (unknown), Jinghui Zhan, Juan Estrada, (unknown), (unknown), (unknown), (unknown), Keegan S. Cooke, Hervé Lebrec, Olivier Nolan-Stevaux	11
4	Abstract 585: Assessing ENPP3 as a renal cancer target for bispecific T-cell engager (BiTE) therapy 2016 ·Cancer Research ·Olivier Nolan-Stevaux, (unknown), Lily Liu, Suzanne Coberly, Patricia McElroy, (unknown), (unknown), (unknown), Tobias Raum, Roman Kischel, Ralf Lutterbuese, Patrick Hoffmann, Peter Kufer	1
5	A novel engineered VEGF blocker with an excellent pharmacokinetic profile and robust anti-tumor activity 2015 ·BMC Cancer ·Lily Liu, Haijia Yu, Xin Huang, (unknown), Song Li, Yan Luo, Zhang Li, (unknown), (unknown), Yao Xiong, Ruliang Zhang, Yi-Hsun Huang, Charles C. Chu, Wenzhi Tian	13
6	Fasting Glucose Levels in Predicting 1-Year All-Cause Mortality in Patients Who Do Not Have Diabetes and Are on Maintenance Hemodialysis 2007 ·Journal of the American Society of Nephrology ·Dan‐Tzu Lin‐Tan, Ja‐Liang Lin, Lihua Wang, Limei Wang, (unknown), Lily Liu, Jeng‐Yi Huang, Yenlin Huang	32
7	Suppression of tumor necrosis factor-induced cell death by inhibitor of apoptosis c-IAP2 is under NF-κB control breakdown → 1997 ·Proceedings of the National Academy of Sciences ·Zhi‐Liang Chu, Timothy A. McKinsey, Lily Liu, (unknown), Michael H. Malim, Dean W. Ballard	778
8	Basal Phosphorylation of the PEST Domain in IκBβ Regulates Its Functional Interaction with the c-rel Proto-Oncogene Product 1996 ·Molecular and Cellular Biology ·Zhi‐Liang Chu, Timothy A. McKinsey, Lily Liu, Xiaoxia Qi, Dean W. Ballard	78

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact